# A Rare Case of Reversible Pulmonary Hypertension Phenotype in a Child with Scurvy: Aetiologies Insights

**Authors:** Mattia Pasquinucci, Luisa Bonsembiante, Sofia Mezzalira, Martina Locallo, Davide Meneghesso

PMC · DOI: 10.3390/reports9010044 · Reports - Clinical Practice and Surgical Cases · 2026-01-30

## TL;DR

A child with scurvy showed reversible pulmonary hypertension, highlighting the link between vitamin C deficiency and vascular changes.

## Contribution

This case reveals a novel connection between scurvy and reversible pulmonary arterial hypertension through metabolic dysregulation.

## Key findings

- Vitamin C and iron deficiencies may trigger a pseudohypoxic state leading to pulmonary hypertension.
- Pulmonary pressures in scurvy-related PAH can normalize rapidly with nutritional supplementation.
- Metabolic dysregulation involving ascorbic acid, iron, and folate disrupts vascular homeostasis.

## Abstract

Background and Clinical Significance: Scurvy, caused by chronic vitamin C deficiency, is re-emerging in Western countries, particularly among pediatric patients with highly selective diets. While its musculoskeletal and mucocutaneous manifestations are well-known, its association with pulmonary arterial hypertension (PAH) is rare and poorly understood. Ascorbic acid and iron are essential cofactors for prolyl hydroxylases (PHD), which regulate Hypoxia-Inducible Factors. Their combined deficiency may trigger a “pseudohypoxic” state, leading to pulmonary vascular remodeling and vasoconstriction. Case Presentation: A 30-month-old female presented with a one-month history of limping, lower limb pain, and gingival hypertrophy. Dietary history revealed an almost exclusive cow’s milk-based intake. Physical examination showed diffuse petechiae, pallor, and right knee edema. Laboratory findings confirmed scurvy (undetectable vitamin C), severe iron-deficiency anemia (Hb: 72 g/L; ferritin: 22 mcg/L; RDW: 30%), folate deficiency, and hyperhomocysteinemia. Notably, elevated copper and vitamin B12 levels suggested a state of metabolic dysregulation. Echocardiography revealed moderate PAH phenotype (estimated sPAP: 47–50 mmHg) and a hyperdynamic contractility. A “perfect storm” mechanism was hypothesized, involving iron–ascorbate-dependent PHD impairment, high-output state, and oxidative-stress-induced hepcidin dysregulation (suggested by elevated copper). Following intravenous vitamin C and multivitamin supplementation, pulmonary pressures normalized within one week. Conclusions: PAH phenotype in scurvy represents a reversible metabolic disruption of pulmonary vascular tone rather than a structural disease. This case underscores the synergistic role of vitamin C, iron, and folate in vascular homeostasis. Clinicians should maintain high suspicion for scurvy in children with selective diets and unexplained PAH, as nutritional restoration is curative.

## Linked entities

- **Proteins:** HAMP (hepcidin antimicrobial peptide)
- **Chemicals:** ascorbic acid (PubChem CID 9888239), iron (PubChem CID 23925), folate (PubChem CID 135405876), copper (PubChem CID 23978), vitamin B12 (PubChem CID 73415824), homocysteine (PubChem CID 778)
- **Diseases:** scurvy (MONDO:0009412), pulmonary arterial hypertension (MONDO:0015924), iron-deficiency anemia (MONDO:0001356), hyperhomocysteinemia (MONDO:0004743)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** HAMP (hepcidin antimicrobial peptide) [NCBI Gene 57817] {aka HEPC, HFE2B, LEAP1, PLTR}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, EPAS1 (endothelial PAS domain protein 1) [NCBI Gene 2034] {aka ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73}, SERPINC1 (serpin family C member 1) [NCBI Gene 462] {aka AT3, AT3D, ATIII, ATIII-R2, ATIII-T1, ATIII-T2}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}
- **Diseases:** Haemorrhagic gingival hypertrophy (MESH:D005884), PH (MESH:D006976), hypochromic microcytic anemia (MESH:C536357), gingival hypertrophy (MESH:D005886), cardiac cateterism (MESH:D006331), systemic hyperinflammation (MESH:D015619), thromboembolic (MESH:D013923), hyperhomocysteinemia (MESH:D020138), cardiomegaly (MESH:D006332), tricuspid regurgitation (MESH:D014262), sinus tachycardia (MESH:D013616), malignant lymphoproliferative disease (MESH:D008232), ascorbic acid deficiency (MESH:D001206), Group 3 PH (MESH:D065627), thrombocytopenia (MESH:D013921), coagulation abnormalities (MESH:D001778), psychomotor agitation (MESH:D011595), folate deficiency (MESH:C562799), PAH (MESH:D000081029), malnutrition (MESH:D044342), deficiencies (MESH:D007153), malabsorption (MESH:D008286), hypertensive (MESH:D006973), Scurvy (MESH:D012614), repolarization abnormalities (MESH:D000014), Thiamine deficiency (MESH:D013832), anemia (MESH:D000740), Hypoxia (MESH:D000860), iron deficiency (MESH:D000090463), Celiac disease (MESH:D002446), iron-deficiency anemia (MESH:D018798), pulmonary venous congestion (MESH:D006940), cardiomyopathy (MESH:D009202), manifestations (MESH:D012877), bleeding (MESH:D006470), tachycardia (MESH:D013610), pleural effusion (MESH:D010996), maculopapular rash (MESH:D005076), hyponatremia (MESH:D007010), edema (MESH:D004487), lactic acidosis (MESH:D000140), primary lung diseases (MESH:D008171), limb pain (MESH:D010146), inflammation (MESH:D007249), injury to (MESH:D014947), disease of sailors (MESH:D004194)
- **Chemicals:** folate (MESH:D005492), glucose (MESH:D005947), vitamin B12 (MESH:D014805), homocysteine (MESH:D006710), vitamin K (MESH:D014812), Na (MESH:D012964), D (MESH:D003903), Fe2+ (-), nitric oxide (MESH:D009569), copper (MESH:D003300), Ascorbic acid (MESH:D001205), iron (MESH:D007501), triglycerides (MESH:D014280), oxygen (MESH:D010100), midazolam (MESH:D008874), vitamin D. (MESH:D014807)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921981/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921981/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921981/full.md

---
Source: https://tomesphere.com/paper/PMC12921981